Genedrive plc (GDR) is a commercial-stage company focused on point-of-care molecular diagnostics. Its Genedrive® molecular diagnostic platform is at the forefront of this technology, offering a rapid, low-cost, simple-to-use device with high sensitivity and specificity. Rapid analysis of samples aids real-time decision-making, whether in clinical, public health or biothreat applications. GDR is developing a portfolio of assays for the Genedrive device, with its hepatitis C virus (HCV) and
21 Nov 2019
Regulatory hurdle leaped: hearing loss assay
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Regulatory hurdle leaped: hearing loss assay
Genedrive Plc (GDR:LON) | 5.6 0 (-8.2%) | Mkt Cap: 8.05m
- Published:
21 Nov 2019 -
Author:
Martin Hall -
Pages:
4
Genedrive plc (GDR) is a commercial-stage company focused on point-of-care molecular diagnostics. Its Genedrive® molecular diagnostic platform is at the forefront of this technology, offering a rapid, low-cost, simple-to-use device with high sensitivity and specificity. Rapid analysis of samples aids real-time decision-making, whether in clinical, public health or biothreat applications. GDR is developing a portfolio of assays for the Genedrive device, with its hepatitis C virus (HCV) and